• S&P 500: 1,351.95
  • Change: 0.15%
$14.24 0.00 (0%)
2/28/2011 4:03 PM

King Pharmaceuticals, Inc. (NYSE:KG)

CAPS Rating: 2 out of 5

The Company is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products.

Current Price $14.24 Mkt Cap $3.56B
Open $0.00 P/E Ratio 41.70
Prev. Close $14.24 Div. (Yield) N/A (N/A)
Daily Range $14.24 - $14.25 Volume 0
52-Wk Range $7.18 - $14.26 Avg. Daily Vol. 0

News & Discussion Boards

More Headlines...

Sorry no news articles available for KG.

More Fool Articles...

Sorry no Fool articles available for KG.

Subject Recs Author Date

Caps

How do you think KG will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

364 Outperform
39 Underperform
 

All-Star Players

108 Outperform
10 Underperform
 

Wall Street

5 Outperform
2 Underperform
 

Top KG Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Survivn2 (63.93)
Submitted October 16, 2008

Pharma in rough times, MFI. Smaller cap than I wanted, but we'll give it a try.

aladha (76.82)
Submitted April 15, 2008

Maybe good long term once they get some direction but the market shares for their "blockbuster" products in terms of actual Rx's dispensed plus huge debt load relative to current position points to this one being flat at best until they manage to… More

KG VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about KG.

Recs

0
Member Avatar btthus (66.47) Submitted: 10/12/2010 11:10:01 AM : Outperform Start Price: $14.16 KG Score: -15.67

Price is now 14.15....
Pfizer will acquire King Pharma for $14.25 per share.

Recs

0
Member Avatar cashman79 (27.43) Submitted: 9/15/2010 9:55:36 AM : Outperform Start Price: $9.31 KG Score: +32.52

watch

Recs

0
Member Avatar coryjobe (88.51) Submitted: 7/24/2010 3:58:39 PM : Outperform Start Price: $8.51 KG Score: +40.89

Recently had a slight setback with their drug Acurox, FDA rejected it but there is still a chance that it will get passed if the regulator says its ok. Right now they plan on submitting a new application in early 2011 with a new version of the drug that will have much better odds of getting approved. This company might not have much growth short term, but in the long term should be very profitable. They have a large number of drugs which should boost numbers in the next couple of years. Also a court ruling is causing one of the generic competitors Skelaxin off the market for now.

Leaderboard

Find the members with the highest scoring picks in KG.

Score Leader

jabajuba77

jabajuba77 (< 20) Score: +76.62

The Score Leader is the player with the highest score across all their picks in KG.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
NoDrachmas 52.08 3/27/2008 3/28/2008 Outperform 1Y $8.55 +66.55% +4.71% +61.84 0 Comment
fosterg09 < 20 3/27/2008 Outperform NS $8.56 +66.36% +4.81% +61.55 0 Comment
Brad2u < 20 4/25/2008 Outperform 1Y $8.91 +59.82% +0.69% +59.13 0 Comment
trader1353 < 20 4/24/2008 Outperform 3Y $8.93 +59.46% +0.81% +58.65 0 Comment
jrkish40 84.13 4/18/2008 4/18/2008 Outperform 3M $8.92 +59.64% +1.11% +58.53 0 Comment
djrocknroll < 20 7/6/2010 Outperform 5Y $7.53 +89.11% +30.61% +58.50 0 Comment
Thaitwist 41.75 4/24/2008 Outperform 3W $8.94 +59.28% +0.97% +58.31 0 Comment
mnkhayes < 20 4/18/2008 Outperform 1Y $8.93 +59.46% +1.35% +58.11 0 Comment
kimonye 81.69 4/10/2008 11/2/2009 Outperform 3Y $8.85 +60.90% +3.08% +57.82 0 Comment
beerfan1 < 20 4/15/2008 Outperform 3Y $8.75 +62.74% +5.52% +57.22 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackCarisandCo 88.55 6/9/2010 Outperform NS $7.71 +84.70% +26.22% +58.47 0 Comment
TrackZacks 70.75 5/5/2010 Underperform 3M $9.64 -4.77% -3.28% +1.49 8/9/2010 @ $9.18 1 Comment
TrackBMOCapital 89.34 4/23/2010 Underperform NS $11.12 +28.06% +11.92% -16.13 0 Comment
TrackGoldmanSach 71.30 4/22/2010 Underperform 5Y $11.38 -23.11% -7.76% +15.35 7/26/2010 @ $8.75 1 Comment
TrackLazardCapit 78.98 10/8/2009 Outperform NS $10.36 +37.45% +27.04% +10.41 0 Comment
TrackZacks 70.75 8/21/2009 Underperform 3M $10.50 +17.05% +11.30% -5.75 3/9/2010 @ $12.29 1 Comment
TrackZacks 70.75 7/8/2009 Outperform 3M $9.27 +13.27% +16.86% -3.60 8/21/2009 @ $10.50 1 Comment
TrackUBS 93.25 4/20/2009 Outperform NS $8.84 +60.18% +38.22% +21.96 10/13/2010 @ $14.16 0 Comment
TrackWellsFargo 92.44 3/16/2009 Outperform NS $7.45 +91.14% +79.00% +12.14 0 Comment
TrackCowenandCo 81.94 11/14/2008 Outperform NS $9.64 +47.72% +55.30% -7.58 0 Comment
TrackJGreenblatt 85.03 4/11/2008 Outperform 1Y $8.88 -0.45% -36.51% +36.06 4/20/2009 @ $8.84 2 Comments
TrackSoros 93.24 9/30/2007 Outperform NS $11.72 +21.50% -7.05% +28.55 1 Comment
TrackCitigroup 93.11 7/17/2007 Underperform NS $19.00 -43.16% -1.39% +41.77 10/19/2007 @ $10.80 0 Comment
TrackZacks 70.75 6/21/2007 Underperform 3M $20.51 -43.78% -14.34% +29.45 8/29/2008 @ $11.53 1 Comment
TrackJGreenblatt 85.03 1/1/2007 Outperform 1Y $15.92 -35.62% +3.69% -39.31 1/2/2008 @ $10.25 1 Comment
TrackBroadpointAmTech 90.21 12/20/2006 Underperform NS $16.17 -15.03% +1.20% +16.23 8/10/2007 @ $13.74 0 Comment
TrackJimCramer 78.02 6/9/2006 Underperform 3W $16.50 -13.70% +15.22% +28.92 0 Comment
TrackJGreenblatt 85.03 4/13/2006 Outperform 1Y $17.65 -9.07% +10.05% -19.11 1/1/2007 @ $16.05 0 Comment

Featured Broker Partners